Patterns of endocrine therapy in a national cohort of early stage HER2-positive breast cancer patients.
Tervonen, Hanna E
Patterns of endocrine therapy in a national cohort of early stage HER2-positive breast cancer patients. [electronic resource] - Pharmacoepidemiology and drug safety 06 2019 - 812-820 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1099-1557
10.1002/pds.4751 doi
Adult
Age Factors
Aged
Anastrozole--therapeutic use
Antineoplastic Agents, Hormonal--standards
Antineoplastic Agents, Immunological--therapeutic use
Antineoplastic Combined Chemotherapy Protocols--standards
Aromatase Inhibitors--therapeutic use
Australia--epidemiology
Breast Neoplasms--drug therapy
Duration of Therapy
Evidence-Based Medicine--standards
Female
Follow-Up Studies
Humans
Kaplan-Meier Estimate
Middle Aged
Neoplasm Staging
Practice Guidelines as Topic
Practice Patterns, Physicians'--standards
Professional Practice Gaps--statistics & numerical data
Receptor, ErbB-2--antagonists & inhibitors
Retrospective Studies
Tamoxifen--therapeutic use
Time Factors
Trastuzumab--therapeutic use
Assessment of Medication Adherence
Patterns of endocrine therapy in a national cohort of early stage HER2-positive breast cancer patients. [electronic resource] - Pharmacoepidemiology and drug safety 06 2019 - 812-820 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1099-1557
10.1002/pds.4751 doi
Adult
Age Factors
Aged
Anastrozole--therapeutic use
Antineoplastic Agents, Hormonal--standards
Antineoplastic Agents, Immunological--therapeutic use
Antineoplastic Combined Chemotherapy Protocols--standards
Aromatase Inhibitors--therapeutic use
Australia--epidemiology
Breast Neoplasms--drug therapy
Duration of Therapy
Evidence-Based Medicine--standards
Female
Follow-Up Studies
Humans
Kaplan-Meier Estimate
Middle Aged
Neoplasm Staging
Practice Guidelines as Topic
Practice Patterns, Physicians'--standards
Professional Practice Gaps--statistics & numerical data
Receptor, ErbB-2--antagonists & inhibitors
Retrospective Studies
Tamoxifen--therapeutic use
Time Factors
Trastuzumab--therapeutic use
Assessment of Medication Adherence